Elizabeth Nalley | Nanotechnology | Editorial Board Member

Published on by Research Chemistry Awards

Editorial Board Member

Elizabeth Nalley
Affiliation Cameron University
Country United States
Scopus ID 57194806203
Documents 16
Citations 197
h-index 6
Subject Area Nanotechnology
Event International Research Chemistry Awards

Elizabeth Nalley is a researcher affiliated with Cameron University in the United States, with a research profile indexed in Scopus under Author ID 57194806203. The supplied bibliographic record identifies 16 documents, 197 citations, and an h-index of 6, with nanotechnology listed as the principal subject area. These indicators provide a bibliometric overview of her indexed research activity and scholarly visibility. [1]

Abstract

Elizabeth Nalley is presented in this academic recognition profile as a researcher associated with Cameron University, United States. Her Scopus-indexed record comprises 16 documents and 197 citations, with an h-index of 6. Nanotechnology is identified as her principal subject area. The profile provides a concise overview of her indexed scholarly activity and bibliometric impact in the context of the International Research Chemistry Awards. [1]

Keywords

Elizabeth Nalley is associated with Cameron University and works within the field of Nanotechnology. Her Scopus Research Profile reflects documented scholarly activity, while bibliometrics such as citations and h-index provide indicators of research impact. Her academic profile also supports recognition as an Editorial Board Member contributing to the research community.[2]

Introduction

Nanotechnology encompasses the study, design, characterization, and application of materials and structures at the nanoscale. Research in this field frequently intersects with chemistry, materials science, physics, engineering, and biomedical applications. Within this multidisciplinary environment, indexed publication records and citation indicators can provide useful quantitative measures of scholarly activity.[1]

Research Profile

The supplied bibliometric profile records 16 Scopus-indexed documents, 197 citations, and an h-index of 6. The h-index indicates that six indexed publications have each received at least six citations within the underlying database record. Citation and publication indicators are database-dependent and may change as additional documents are indexed or citation records are updated. [3]

Research Contributions

The designation of nanotechnology as the principal subject area places the profile within a field characterized by interdisciplinary research and the development of nanoscale materials, structures, and technologies. The available bibliometric indicators can therefore be considered as one component of a broader scholarly assessment.[2]

Publications

The supplied Scopus record identifies 16 indexed documents associated with Elizabeth Nalley. Because individual publication titles, journal details, publication years, and  identifiers were not provided in the source information for this profile, specific publication-level claims are not introduced here. The Scopus author profile is the appropriate source for reviewing the current indexed publication list. [3]

Research Impact

The supplied profile reports 197 citations and an h-index of 6. These measures indicate that the indexed publication record has received measurable scholarly attention. Citation counts should nevertheless be understood as quantitative indicators rather than comprehensive measures of research quality, societal relevance, or scientific originality. [1]

Award Suitability

Elizabeth Nalley’s documented affiliation with Cameron University, nanotechnology subject classification, 16 Scopus-indexed documents, 197 citations, and h-index of 6 provide identifiable scholarly indicators relevant to an academic recognition profile. These characteristics may support consideration for recognition associated with the International Research Chemistry Awards.[2]

Conclusion

Elizabeth Nalley is associated with Cameron University in the United States and has a Scopus-indexed research profile focused on nanotechnology. The supplied record reports 16 documents, 197 citations, and an h-index of 6. These indicators provide a concise quantitative representation of her indexed scholarly activity and may serve as supporting evidence in an academic recognition assessment. [3]

References

  1. Elsevier. (n.d.). Scopus author details: Elizabeth Nalley, Author ID 57194806203. Scopus.
    https://www.scopus.com/pages/authors/57194806203
  2. International Research Chemistry Awards. (n.d.).
    https://researchchemistry.org
  3. Nalley, E. A. (2023). Technology supporting green chemistry in chemical education. Physical Sciences Reviews, 8(3), 345–362.
    https://doi.org/10.1515/psr-2020-0002

Avinash Baji | Nanomaterials | Editorial Board Member

Published on by Research Chemistry Awards

Editorial Board Member

Avinash Baji
Affiliation La Trobe University – Bundoora Campus
Country Australia
Scopus ID 12763832600
Documents 97
Citations 4,366
h-index 33
Subject Area Nanomaterials
Event International Research Chemistry Awards
ORCID 0000-0001-9611-3381

Avinash Baji is a researcher affiliated with La Trobe University in Australia whose academic profile is associated with the field of nanomaterials. His scholarly record, as represented by the supplied Scopus information, comprises 97 documents, 4,366 citations, and an h-index of 33. These indicators provide a bibliometric overview of his research activity and scholarly visibility. [1]

Abstract

This profile documents the academic recognition of Avinash Baji as an Editorial Board Member in the context of the International Research Chemistry Awards. The supplied academic information identifies La Trobe University, Australia, as his institutional affiliation and nanomaterials as the principal subject area.[1]

Keywords

Avinash Baji, Nanomaterials, Materials Science,  Nanotechnology, Advanced Materials, Nanoscience, Materials Research, Scientific Innovation, Research Excellence, Scholarly Impact, Chemistry Research, Nanoscale Science, Research Publications, Citation Impact, Academic Achievement, Research Collaboration, Functional  [2]

Introduction

Nanomaterials research encompasses the design, characterization, processing, and application of materials whose properties are strongly influenced by nanoscale structure. The field intersects chemistry, materials science, engineering, physics, and related disciplines. Within this research environment, scholarly publication.[1]

Research Profile

The available research profile places Avinash Baji within the nanomaterials subject area and records an institutional affiliation with La Trobe University in Australia. The supplied Scopus data indicate 97 indexed documents. These figures can be interpreted as indicators of the scale and citation visibility of the indexed scholarly record. [4]

Research Contributions

Based on the supplied subject classification, the research profile is situated within nanomaterials, a broad area concerned with nanoscale materials and their structure–property relationships. Research in this area may involve synthesis, characterization, functionalization, processing, and evaluation of advanced materials for scientific and technological applications. [2]

Publications

The supplied Scopus information reports 97 documents associated with the researcher’s author profile. This document count provides a quantitative description of indexed scholarly output. Because individual publication titles, journals, publication years, and identifiers were not supplied as part of the source data, no specific publication-level claims are made in this profile. [3]

Research Impact

Bibliometric indicators should nevertheless be interpreted in relation to disciplinary practices, publication age, collaboration patterns, database coverage, and the characteristics of the relevant research community. Accordingly, the reported indicators are presented here as profile information rather than as a standalone measure of research quality. [2]

Award Suitability

The designation presented on this page is Editorial Board Member. It should be understood as an academic recognition designation associated with the stated event and should not be interpreted as an independent ranking of the researcher or as confirmation of a particular award outcome unless separately documented by the awarding organization. [3]

Conclusion

Avinash Baji’s supplied academic profile identifies La Trobe University in Australia as his institutional affiliation and nanomaterials as his subject area. The associated Scopus record is reported to contain 97 documents, 4,366 citations, and an h-index of 33. Together with the researcher’s ORCID identifier, these records provide a structured basis for academic identification and bibliometric description. [4]

References

  1. Elsevier. (n.d.). Scopus author details: Avinash Baji, Author ID 12763832600. Scopus.
    https://www.scopus.com/pages/authors/12763832600
  2. ORCID. (n.d.). Avinash Baji ORCID record. ORCID.
    https://orcid.org/0000-0001-9611-3381
  3. International Research Chemistry Awards. (n.d.).
    https://researchchemistry.org
  4. Kavuru, P., Baji, A., Sharma, H., & Gupta, R. K. (2026). Role of lubricant viscosity on fog harvesting performance over lubricant infused nanostructured surfaces. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 750, 141441.
    https://doi.org/10.1016/j.colsurfa.2026.141441

Riham Bokhtia | Molecular | Editorial Board Member

Published on by Research Chemistry Awards

Editorial Board Member

  Riham Bokhtia
Affiliation Faculty of Pharmacy, Zagazig University
Country Egypt
Scopus ID 57209660751
Documents 13
Citations 152
h-index 6
Subject Area Molecular
Event International Research Chemistry Awards
ORCID 0000-0001-5326-7364

Riham Bokhtia is affiliated with the Faculty of Pharmacy at Zagazig University, Egypt, and has developed a research profile represented in international scholarly indexing systems. The available Scopus record identifies 13 documents, 152 citations, and an h-index of 6, providing quantitative indicators of publication activity and citation visibility. [1]

Abstract

Riham Bokhtia is a researcher affiliated with the Faculty of Pharmacy, Zagazig University, Egypt. Her scholarly profile is represented in the Scopus database by 13 indexed documents, 152 citations, and an h-index of 6. The available information places her research within the molecular subject area and provides a basis for describing her academic publication activity, research visibility. [1]

Keywords

Riham Bokhtia is a researcher affiliated with the Faculty of Pharmacy at Zagazig University, Egypt, with research interests spanning molecular chemistry. Her scholarly profile is represented through Scopus-indexed publications while her Scopus research profile provides indicators of scholarly impact. recognizing research contributions within chemistry and related scientific disciplines.[2]

Introduction

Academic research profiles provide a structured means of evaluating scholarly activity through publication records, citation patterns, and bibliometric indicators. Scopus is a major abstract and citation database used to index scholarly literature and to provide author-level indicators such as document counts, citation counts, and h-index values. [1]

Research Profile

The available bibliometric information identifies a documented research record associated with a Scopus Author profile. The indexed publications demonstrate scholarly activity and citation engagement, reflecting an established publication footprint and research visibility within the academic literature and broader scholarly presence in molecular research.[4]

Research Contributions

Bokhtia’s research profile is situated at the intersection of molecular science and pharmaceutical research. The molecular subject designation provides a broad indication of the scientific domain represented in the supplied academic record. Detailed assessment of individual research contributions should be based on the full-text publications and documented findings associated with each indexed work. [3]

Publications

For formal academic evaluation, the publication record can be reviewed through the researcher’s Scopus profile and, where available, individual publisher records and DOI registrations. These sources allow publication titles, journal information, publication years, authorship, citation metadata, and persistent identifiers to be verified independently. [4]

Research Impact

The reported 152 citations provide an observable indicator of scholarly use or discussion of the indexed documents, while the h-index of 6 indicates that at least six indexed publications have each received at least s ix citations under the relevant database calculation. Bibliometric indicators should, however, be interpreted alongside disciplinary norms. [2]

Award Suitability

On the supplied evidence, her profile demonstrates established scholarly activity through 13 Scopus-indexed documents, 152 citations, and an h-index of 6.  Final award assessment should additionally consider the originality, significance, quality, and documented scientific contribution of the underlying publications and any applicable award criteria. [3]

Conclusion

Riham Bokhtia’s academic profile reflects a documented research presence in the molecular and pharmaceutical research context. Her Scopus record reports 13 documents, 152 citations, and an h-index of 6, providing quantitative evidence of publication activity and citation visibility. These indicators support consideration of her scholarly profile within an academic recognition context. [4]

References

  1. Elsevier. (n.d.). Scopus author details: Riham Bokhtia, Author ID 57209660751. Scopus.
    https://www.scopus.com/pages/authors/57209660751
  2. ORCID. (n.d.). ORCID record for Riham Bokhtia.
    https://orcid.org/0000-0001-5326-7364
  3. International Research Chemistry Awards. (n.d.).
    https://researchchemistry.org
  4. Bokhtia, R. M., et al. (n.d.). Imidazole–sulfonamide hybrid conjugate: A privilege scaffold with significant therapeutic potential
    https://doi.org/10.1016/j.ejmcr.2025.100321

Salah Abusnana | Obesity | Best Researcher Award

Published on by Research Chemistry Awards

Prof. Salah Abusnana | Obesity | Best Researcher Award

University of Sharjah Center for Diabetes | United Arab Emirates

Prof. Salah Abusnana is an accomplished clinician, academic leader, and researcher in diabetes, endocrinology, and internal medicine, with over three decades of clinical practice and significant contributions to medical education and healthcare management. He earned his MSc in Neuroendocrinology, PhD from Imperial College London, and advanced postgraduate qualifications including MRCP and CCST in Endocrinology, Diabetes, and Internal Medicine. His extensive career spans senior clinical positions across major London university hospitals and leading roles in the UAE as Senior Consultant, Head of Diabetes and Endocrine Department, Professor, Deputy Chair of Clinical Sciences, Medical Director at RCDR, and Chief Medical Officer at SKMCA. His research focuses on neuroendocrinology, obesity, appetite regulation, diabetes care, and metabolic disorders, leading to numerous peer-reviewed publications and the establishment of fully structured research units and national-level programs. He has supervised MSc and PhD scholars and played key roles in developing diabetes guidelines, PHC training programs, and national research initiatives. A recognized leader, he contributed significantly to hospital commissioning, curriculum development, and clinical service expansion. Widely respected for his work, he continues to advance diabetes research, education, and clinical excellence through leadership roles and collaborative initiatives.

Profiles: Scopus | Orcid

Featured Publications

Ramakrishnan, R.K., Srivastava, A., Rajan, R., Abusnana, S., & Mussa, B.M. (2024). “Investigating the role of an immediate early gene FOS as a potential regulator of autophagic response to hypoglycemia in embryonic hypothalamic neurons.” Clinical and Translational Science.

Hassanein, M., Sabbour, H., Al Awadi, F., Abusnana, S., Afandi, B., Al Kaabi, J., Bashier, A., Cosentino, F., El Tamimi, H., Farghali, M., et al. (2023). “Cardiometabolic Guidelines: Cardiovascular Risk Assessment and Management in Patients with Dysglycemia.” Dubai Diabetes and Endocrinology Journal.

Alnimer, A., Bhamidimarri, P.M., Talaat, I.M., Alkhayaal, N., Eltayeb, A., Ali, N., Abusnana, S., Hamoudi, R., & Bendardaf, R. (2023). “Association Between Expression of Vitamin D Receptor and Insulin-Like Growth Factor 1 Receptor Among Breast Cancer Patients.” World Journal of Oncology.

Zakaria, H., Abusanana, S., Mussa, B.M., Al Dhaheri, A.S., Stojanovska, L., Mohamad, M.N., Saleh, S.T., Ali, H.I., & Ismail, L.C. (2023). “The Role of Lifestyle Interventions in the Prevention and Treatment of Gestational Diabetes Mellitus.” Medicina.

Mussa, B.M., Srivastava, A., Al-Habshi, A., Mohammed, A.K., Halwani, R., & Abusnana, S. (2021). “Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy.” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.

Bendardaf, R., Saheb Sharif-Askari, F., Saheb Sharif-Askari, N., Guraya, S.Y., AlMadhi, S.A., & Abusnana, S. (2020). “Incidence and Clinicopathological Features of Breast Cancer in the Northern Emirates: Experience from Sharjah Breast Care Center.” International Journal of Women’s Health.

Saheb Sharif-Askari, F., Saheb Sharif-Askari, N., Halwani, R., Abusnana, S., Hamoudi, R., & Sulaiman, N. (2020). “Low Vitamin D Serum Level Is Associated with HDL-C Dyslipidemia and Increased Serum Thrombomodulin Levels of Insulin-Resistant Individuals.” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.

Mussa, B.M., Schauman, M., Ramalingam, V., Skaria, S., & Abusnana, S. (2019). “Personalized intervention to improve stress and sleep patterns for glycemic control and weight management in obese Emirati patients with type 2 diabetes: a randomized controlled clinical trial.” Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.

Yong-Keun Jung | Biomolecules | Best Researcher Award

Published on by Research Chemistry Awards

Prof. Yong-Keun Jung | Biomolecules | Best Researcher Award

Seoul National University | South Korea

Prof. Yong-Keun Jung is a distinguished molecular biologist and neurodegeneration researcher recognized for his pioneering contributions to understanding cell death, autophagy, and neurodegenerative disease mechanisms. He earned his Ph.D. in Molecular Pharmacology and Biology from Albert Einstein College of Medicine, following an M.S. in Molecular Biology and a B.S. in Zoology from Seoul National University. After completing postdoctoral research at Harvard Medical School, he served as a professor at the Gwangju Institute of Science and Technology, where he also chaired the Department of Life Science and directed major academic programs such as the BK21 initiative. At Seoul National University, he held several leadership roles, including Director of the Institute of Molecular and Cell Biology, Vice President of the Bio-MAX Institute, and President of the Korea Society for Neurodegenerative Disease. His research focuses on molecular pathways of neurodegeneration, protein homeostasis, autophagy regulation, and therapeutic target discovery. As an editor and editorial board member for leading international journals, he has significantly shaped scientific discourse in biophysics, biochemistry, and molecular neuroscience. With numerous academic honors and contributions, Prof. Jung continues to influence the global research community, concluding a career marked by innovation, leadership, and lasting scientific impact.

Profiles: Scopus | Orcid

Featured Publications

Park, G., Kim, N., Kim, S.-Y., Lee, H., Li, C.M., Seol, J.H., Choi, S.-Y., & Jung, Y.-K. (2025). “TUSC3 regulates ERMA-mediated Mg²⁺ uptake for synaptic function and neurodevelopment” in Nature Communications.

Kim, Y., Kim, N., Lee, W., Kim, Y., Kim, D., Park, J., & Jung, Y.-K. (2025). “More 26S and 30S proteasomes are beneficial in proteinopathy” in Proceedings of the National Academy of Sciences.

Li, C.M., & Jung, Y.-K. (2025). “ER quality control through reticulophagy and protein secretion” in Autophagy.

Baek, S., Chang, J.-W., Yoo, S.-M., Choo, J., Jung, S., Nah, J., & Jung, Y.-K. (2024). “TMEM9 activates Rab9-dependent alternative autophagy through interaction with Beclin1” in Cellular and Molecular Life Sciences.

Kang, J., Li, C.M., Kim, N., Baek, J., & Jung, Y.-K. (2024). “Non-autophagic Golgi-LC3 lipidation facilitates TFE3 stress response against Golgi dysfunction” in The EMBO Journal.

Li, C.M., Kang, J., Baek, J., Kim, Y., Park, H., & Jung, Y.-K. (2024). “Cytosolic FKBPL and ER-resident CKAP4 co-regulates ER-phagy and protein secretion” in Nature Communications.

Kim, S.-H., Cho, Y.-S., Kim, Y., Park, J., Yoo, S.-M., Gwak, J., Kim, Y., Gwon, Y., Kam, T., & Jung, Y.-K. (2023). “Endolysosomal impairment by binding of amyloid beta or MAPT/Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease” in Autophagy.